Manager, US Health Outcomes & Epidemiology
GSK
Disclosure: GSK (Employee, Shareholder)
Brandon J. Patterson, PharmD, PhD is Director, US Health Outcomes & Epidemiology at GSK. At GSK, he first supported the hepatitis vaccine portfolio and then took a leading role on the Shingrix ACIP recommendation evidence generation and launch (including development of the Shingrix US cost-effectiveness model). Brandon is a graduate of the University of Texas at Austin College of Pharmacy and a licensed pharmacist. He completed a PhD in Pharmaceutical Socioeconomics at the University of Iowa. Before coming to GSK, he was on faculty at the University of the Sciences College of Pharmacy and maintains an adjunct position. Brandon has served in leadership capacities with state and national pharmacy associations including Pennsylvania Pharmacists Association and the American Pharmacists Association. He lives in Philadelphia with his wife and three young children.
